HCPCS Level II

J2351

Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq

Ask Rivvi

50242-0554-01 Ocrevus Zunovo, Genentech, Inc.. Billable units per 11-digit NDC: 920.

Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.

Free to start. Most teams are using it the same day.